Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR Galapagos NV (GXE.BE) Follow Compare 24.08 +0.04 +(0.17%) As of 11:55:06 AM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for GXE.BE 1D 5D -5.49% 1M 8.47% 3M -5.86% 6M -2.98% YTD -8.30% 1Y -23.94% 5Y -86.77% All -52.13% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: GXE.BE View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Galapagos to Present at Upcoming Investor Conferences Galapagos (AMS:GLPG) adds €185m to market cap in the past 7 days, though investors from five years ago are still down 89% Galapagos receives transparency notification and 13D filing from Tang Capital Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update Galapagos NV (GLPG): A Cheap Biotech Stock to Invest In Now Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40% Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Galapagos NV (AMS:GLPG) stock most popular amongst retail investors who own 56%, while public companies hold 25%